Ono Pharmaceutical Co Ltd's ticker is OPHLY and the CUSIP is 682736103. A total of 2 filers reported holding Ono Pharmaceutical Co Ltd in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $158,000 | +24.4% | 21,116 | +0.3% | 0.02% | -5.0% |
| Q3 2019 | $127,000 | +2.4% | 21,047 | 0.0% | 0.02% | 0.0% |
| Q2 2019 | $124,000 | +12300.0% | 21,047 | +11401.1% | 0.02% | – |
| Q1 2019 | $1,000 | 0.0% | 183 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | -99.2% | 183 | -95.9% | 0.00% | -100.0% |
| Q3 2018 | $122,000 | +12100.0% | 4,483 | +2349.7% | 0.04% | – |
| Q2 2018 | $1,000 | 0.0% | 183 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 183 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | 0.0% | 183 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | 0.0% | 183 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 183 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | -50.0% | 183 | -56.7% | 0.00% | -100.0% |
| Q4 2016 | $2,000 | – | 423 | +531.3% | 0.00% | – |
| Q3 2016 | $0 | -100.0% | 67 | -79.6% | 0.00% | -100.0% |
| Q2 2016 | $3,000 | +50.0% | 329 | +296.4% | 0.00% | +100.0% |
| Q1 2016 | $2,000 | – | 83 | +124.3% | 0.00% | – |
| Q4 2015 | $0 | – | 37 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|